178 related articles for article (PubMed ID: 38592525)
1. Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes.
Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB
Support Care Cancer; 2024 Apr; 32(5):278. PubMed ID: 38592525
[TBL] [Abstract][Full Text] [Related]
2. Acute, long-term or non-vincristine-induced peripheral neuropathy among non-Hodgkin lymphoma survivors: Symptoms, daily activities, functional status, and quality of life.
Su YC; Lai YH; Hsieh ST; Teng CJ; Lee YH
Eur J Oncol Nurs; 2024 Apr; 69():102540. PubMed ID: 38461728
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
[TBL] [Abstract][Full Text] [Related]
4. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
5. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
6. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
[TBL] [Abstract][Full Text] [Related]
7. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.
Sands S; Ladas EJ; Kelly KM; Weiner M; Lin M; Ndao DH; Dave A; Vahdat LT; Bender JG
Support Care Cancer; 2017 Mar; 25(3):701-708. PubMed ID: 27830395
[TBL] [Abstract][Full Text] [Related]
8. Prevention of vincristine-induced peripheral neuropathy by protecting the endothelial glycocalyx shedding.
Ohmura K; Kinoshita T; Tomita H; Okada H; Shimizu M; Mori K; Taniguchi T; Suzuki A; Iwama T; Hara A
Biochem Biophys Res Commun; 2024 Jan; 691():149286. PubMed ID: 38016339
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
Sawaki A; Miyazaki K; Yamaguchi M; Takeuchi T; Kobayashi K; Imai H; Tawara I; Ono R; Nosaka T; Katayama N
Int J Hematol; 2020 May; 111(5):686-691. PubMed ID: 31993939
[TBL] [Abstract][Full Text] [Related]
10. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
Tunjungsari DA; Gunawan PI; Ugrasena IDG
J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
[TBL] [Abstract][Full Text] [Related]
11. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.
van de Velde ME; van den Berg MH; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van Litsenburg RRL
Cancer Med; 2021 Nov; 10(22):8172-8181. PubMed ID: 34725942
[TBL] [Abstract][Full Text] [Related]
12. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
Triarico S; Romano A; Attinà G; Capozza MA; Maurizi P; Mastrangelo S; Ruggiero A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923421
[TBL] [Abstract][Full Text] [Related]
13. [A cohort study of vincristine-induced peripheral neuropathy in children].
Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
[TBL] [Abstract][Full Text] [Related]
14. Association of CEP72 rs924607 TT Genotype with Vincristine-induced Peripheral Neuropathy Measured by Motor Nerve Conduction Studies.
Kavčič M; Zečkanović A; Jazbec J; Debeljak M
Klin Padiatr; 2020 Nov; 232(6):331-333. PubMed ID: 32877958
[TBL] [Abstract][Full Text] [Related]
15. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
Centanni M; van de Velde ME; Uittenboogaard A; Kaspers GJL; Karlsson MO; Friberg LE
Clin Pharmacokinet; 2024 Feb; 63(2):197-209. PubMed ID: 38141094
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).
Uittenboogaard A; van den Berg MH; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Kaspers GJL; van de Velde ME
Cancer Med; 2023 Oct; 12(19):19480-19490. PubMed ID: 37732486
[TBL] [Abstract][Full Text] [Related]
17. Vincristine-induced peripheral neuropathy: A mini-review.
Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
[TBL] [Abstract][Full Text] [Related]
18. Vincristine-induced peripheral neuropathy in pediatric cancer patients.
Mora E; Smith EM; Donohoe C; Hertz DL
Am J Cancer Res; 2016; 6(11):2416-2430. PubMed ID: 27904761
[TBL] [Abstract][Full Text] [Related]
19. Vincristine-induced peripheral neurotoxicity: A prospective cohort.
Nama N; Barker MK; Kwan C; Sabarre C; Solimano V; Rankin A; Raabe J; Ross CJ; Carleton B; Zwicker JG; Rassekh SR
Pediatr Hematol Oncol; 2020 Feb; 37(1):15-28. PubMed ID: 31682156
[TBL] [Abstract][Full Text] [Related]
20. Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.
Schouten SM; van de Velde ME; Kaspers GJL; Mokkink LB; van der Sluis IM; van den Bos C; Hartman A; Abbink FCH; van den Berg MH
Support Care Cancer; 2020 Jun; 28(6):2867-2873. PubMed ID: 31732853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
